Abstract
The cellular regulation mechanism of Na-K-Cl cotransport was studied in dispersed acinar cells of the guinea pig nasal gland by a microfluorimetric imaging method using the Na(+)-sensitive dye sodium-binding benzofuran isophthalate. Addition of 1 micron acetylcholine (ACh) induced an immediate increase in intracellular Na+ concentration ([Na+]i) by 36.7 +/- 9.9 mM, which was almost completely abolished by the addition of atropine. The increased [Na+]i after cholinergic stimulation was due to the external (Cl-)-dependent cotransport system (about 80% of the total Na+ influx) and the dimethyl amiloride-sensitive (Na+)-H+ exchange system (of about 20%). The ACh-induced increase in [Na+]i was dependent on extracellular Ca2+ and was prevented by pretreatment with 8-(N, N-diethylamino)octyl-3,4,5-trimethoxybenzoate or O-O'-bis(2-aminophenyl)ethyleneglycol-N, N, N', N'-tetraacetic acid tetraacetoxymethylester. Addition of 1 microns ionomycin mimicked the ACh-induced increase in [Na+]i which was dependent on external Cl-. Moreover, both a calmodulin antagonist trifluoperazine and a myosin light chain kinase inhibitor ML-7 reduced the ACh-induced response in [Na+]i. However, the following treatment did not affect the basal [Na+]i nor the ACh-induced increase in [Na+]i: (i) addition of dibutyryl cAMP, 8-Br-cGMP, or phorbol 12-myristate 13-acetate, (ii) pretreatment of protein kinase inhibitors, H-89, H-8, H-7 or chelerythrine, (iii) prevention of cytosolic Cl- efflux by the addition of diphenylamine-2-carboxylic acid or, (iv) prevention of cytosolic K+ efflux by the addition of charybdotoxin.(ABSTRACT TRUNCATED AT 250 WORDS)
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acetylcholine / pharmacology
-
Alkaloids
-
Animals
-
Benzophenanthridines
-
Biological Transport / drug effects
-
Bucladesine / pharmacology
-
Bumetanide / pharmacology
-
Calcium / physiology
-
Calmodulin / antagonists & inhibitors
-
Calmodulin / physiology
-
Carrier Proteins / antagonists & inhibitors
-
Carrier Proteins / metabolism*
-
Charybdotoxin / pharmacology
-
Cholinergic Fibers / physiology*
-
Cyclic AMP / pharmacology
-
Cyclic AMP / physiology
-
Cyclic GMP / analogs & derivatives
-
Cyclic GMP / pharmacology
-
Cyclic GMP / physiology
-
Enzyme Inhibitors / pharmacology
-
Exocrine Glands / drug effects
-
Exocrine Glands / innervation
-
Exocrine Glands / metabolism*
-
Furosemide / pharmacology
-
Guinea Pigs
-
Ionomycin / pharmacology
-
Ionophores / pharmacology
-
Isoquinolines / pharmacology
-
Nasal Cavity*
-
Phenanthridines / pharmacology
-
Protein Kinase Inhibitors
-
Protein Kinases / physiology
-
Second Messenger Systems
-
Signal Transduction / drug effects*
-
Sodium / metabolism*
-
Sodium-Potassium-Chloride Symporters
-
Sulfonamides*
-
Tetradecanoylphorbol Acetate / pharmacology
-
Trifluoperazine / pharmacology
-
Vasoactive Intestinal Peptide / pharmacology
Substances
-
Alkaloids
-
Benzophenanthridines
-
Calmodulin
-
Carrier Proteins
-
Enzyme Inhibitors
-
Ionophores
-
Isoquinolines
-
Phenanthridines
-
Protein Kinase Inhibitors
-
Sodium-Potassium-Chloride Symporters
-
Sulfonamides
-
Bumetanide
-
Charybdotoxin
-
Trifluoperazine
-
8-bromocyclic GMP
-
Vasoactive Intestinal Peptide
-
Ionomycin
-
Bucladesine
-
Furosemide
-
Sodium
-
Cyclic AMP
-
chelerythrine
-
Protein Kinases
-
Cyclic GMP
-
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide
-
Acetylcholine
-
Tetradecanoylphorbol Acetate
-
Calcium